EverSource Wealth Advisors’s Regencell Bioscience RGC Stock Holding History

EverSource Wealth Advisors’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.03K	Sell	498 -420	-46%	-$10.1K	﹤0.01%	3528
2026 Q1	$23.3K	Buy	918 +368	+67%	+$10.4K	﹤0.01%	2409
2025 Q4	$11.6K	Buy	+550	New	+$8.94K	﹤0.01%	2725

Other funds holding RGC

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

EverSource Wealth Advisors's RGC Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Regencell Bioscience (RGC) stake by 46% in Q2 2026, selling an estimated $10.1K and leaving 498 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #3528.

EverSource Wealth Advisors first reported a position in RGC in Q4 2025 and has held it in 3 quarters since. The position peaked at $23.3K in Q1 2026. 2 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

EverSource Wealth Advisors held 498 shares of Regencell Bioscience worth $3.03K as of Q2 2026.
EverSource Wealth Advisors sold 420 Regencell Bioscience shares in Q2 2026, an estimated $10.1K.
Regencell Bioscience made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3528 holding.
EverSource Wealth Advisors first reported a position in Regencell Bioscience in Q4 2025 and has held it in 3 quarters since.
EverSource Wealth Advisors's Regencell Bioscience position peaked at $23.3K in Q1 2026.
2 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.